Does ENALAPRIL Cause Basal cell carcinoma? 39 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 39 reports of Basal cell carcinoma have been filed in association with ENALAPRIL (Enalapril maleate oral solution). This represents 0.5% of all adverse event reports for ENALAPRIL.
39
Reports of Basal cell carcinoma with ENALAPRIL
0.5%
of all ENALAPRIL reports
0
Deaths
13
Hospitalizations
How Dangerous Is Basal cell carcinoma From ENALAPRIL?
Of the 39 reports, 13 (33.3%) required hospitalization, and 1 (2.6%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENALAPRIL. However, 39 reports have been filed with the FAERS database.
What Other Side Effects Does ENALAPRIL Cause?
Acute kidney injury (916)
Drug ineffective (599)
Hypotension (556)
Dyspnoea (514)
Hypertension (451)
Hyperkalaemia (448)
Drug interaction (441)
Angioedema (412)
Off label use (347)
Diarrhoea (342)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which ENALAPRIL Alternatives Have Lower Basal cell carcinoma Risk?
ENALAPRIL vs ENALAPRIL\HYDROCHLOROTHIAZIDE
ENALAPRIL vs ENALAPRIL\LERCANIDIPINE
ENALAPRIL vs ENASIDENIB
ENALAPRIL vs ENBREL
ENALAPRIL vs ENCORAFENIB